Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

The partnership is the first time Medtronic has integrated its insulin pumps with a sensor developed outside of the company.

Medtronic has announced the broad U.S. commercial launch of the MiniMed 780G insulin pump system integrated with the Instinct sensor, made by Abbott and designed exclusively for MiniMed systems.

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Medtronic made headlines twice this week. First, the company launched its MiniMed 780G insulin pump system integrated with ...

Minnesota medtech giant Medtronic found positive momentum Tuesday morning as it faced down what top executives see as a critical moment for the maker of innovative medical devices and procedures for ...

Medtronic's cardiovascular sales rise 10.8% to $3.44 bln CEO emphasizes on cardiology and neuroscience M&A CFO confirms diabetes business to go public in 2026 Nov 18 (Reuters) - Medtronic (MDT.N), ...

FDA clears Medtronic robot for urologic surgeries, enabling use in prostatectomy, nephrectomy and cystectomy across select U.S. hospitals.

Medtronic Plc (NYSE: MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. A fully Implantable insulin pump was ...

Medtronic (NYSE: MDT) today announced new data demonstrating the health economic benefits of its MiniMed 780G system.

When considering what names to put on your watch list, focus on stocks with an 80 or higher RS Rating. MedtronicMDT stock now meets that criteria, with an increase from 67 to 82 Wednesday. The Ireland ...